Financial results for the period ended September 30, 2025
As filed · Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
What happened
FactDr. Reddy's Laboratories' Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2025, during a meeting on October 24, 2025. The company has provided unaudited consolidated and standalone financial results prepared in compliance with both International Financial Reporting Standards and Indian Accounting Standards, along with limited review reports from statutory auditors.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnSo, altogether, right now, we are targeting 27.
It should be in the range of tens of millions of dollars, that specific launch.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- I believe, 100 plus of million dollars coming to us as a growth in the next 2 to 3 years from that. (management committed by H1 FY28)
- So, altogether, right now, we are targeting 27. (management committed by FY27)
Evidence
- Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q3 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%